Programmed cell death may be 1.8 billion year – EurekAlert

Apoptosis, often referred to as programmed cell death, is a fundamental process crucial to the growth and development of multicellular organisms. This process, or a primordial form of it, is also observed in single-celled eukaryotes like yeast and other microeukaryotes (aka protists). The origin of eukaryotic apoptosis remains an open question in biology. However, studies have noted that many apoptosis-initiating factors have a bacterial or mitochondrial origin, providing a clue into the evolutionary history of this widespread phenomenon. In a new study published in Genome Biology and Evolution, scientists from the Institute of Biochemistry and Biophysics of the Polish Academy of Sciences reveal that many apoptotic factors may trace their origins to the time of mitochondrial domestication, suggesting remarkable conservation over the span of 1.8 billion years.

The processes triggering apoptosis exhibit striking similarities among various diverse eukaryotes: an increase in mitochondrial membrane permeability sets in motion a cascade of events involving proteins called apoptosis-inducing factors (AIFs), kickstarting the pathway that culminates in cell death. According to phylogenetic analyses, these AIFs usually have a bacterial/mitochondrial origin. To shed further light on the evolution of apoptosis across eukaryotes, a team led by Szymon Kaczanowski and Urszula Zielenkiewicz investigated the functional conservation of apoptotic factors through a yeast complementation test. The researchers replaced each of four apoptotic genes in yeast with related proteins from diverse eukaryotes and prokaryotes. They then treated the new yeast strains with apoptosis-inducing agents to evaluate whether the introduced genes maintained the ability to induce apoptosis in yeast.

Remarkably, the study found that distantly related proteins from plants, animals, slime molds, and bacteria were largely able to functionally substitute for the original yeast proteins. This surprising finding suggests that ancient mechanisms of cell death have been evolutionarily conserved since the domestication of mitochondria, says Kaczanowski and Zielenkiewicz, an event that occurred approximately 1.8 billion years ago.

The studys findings further support an endosymbiotic origin of apoptosis, a hypothesis that was first proposed by Guido Kroemer in 1997. Kroemer suggested that the bacterial precursors of mitochondria produced both toxins (apoptotic factors) and antitoxins (anti-apoptotic factors). In this scenario, the antitoxins acted as addiction molecules, ensuring the persistence of the symbiont. Driven by this evolutionary conflict between bacterial endosymbionts and hosts, the toxins eventually evolved into the apoptotic factors we recognize today.

Kaczanowski and Zielenkiewicz present an alternative scenario for the evolution of apoptosis. They propose that early protoeukaryotes were predators, relying on bacterial prey. These bacteria, in response to predation, produced toxins as a defense mechanism. Over time, these bacteria were domesticated to serve as mitochondria within eukaryotic cells, and their toxins evolved into apoptotic factors. The different families of AIFs present today and their sporadic distribution across distantly related eukaryotes suggest the existence of multiple redundant toxins in the protomitochondria and hint at a coevolutionary arms race between protomitochondria and their protoeukaryotic hosts.

Regardless of whether apoptosis originates from an endosymbiotic toxin/antitoxin system or from a predator/prey dynamic, the studys findings suggest that the intricate balance between life and death within eukaryotic cells is deeply rooted in the origin of mitochondria, opening up new avenues for research into the coevolution of mitochondria and eukaryotes, as well as the ancient origins of cell death mechanisms. Furthermore, a similar approach could be used to look at other ancient cellular mechanisms beyond programmed cell death and to ask to what extent conflicts among partners/participants have driven the evolution of genome features. Future studies may reveal the evolutionary history of other aging mechanisms and could make a significant contribution to aging studies, note Kaczanowski and Zielenkiewicz, emphasizing the broader implications of their research.

Genome Biology and Evolution

Observational study

Cells

Apoptotic Factors Are Evolutionarily Conserved Since Mitochondrial Domestication

11-Oct-2023

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

Original post:
Programmed cell death may be 1.8 billion year - EurekAlert

New study confirms presence of flesh-eating and illness-causing … – Science Daily

When Hurricane Ian struck southwest Florida in September 2022, it unleashed a variety of Vibrio bacteria that can cause illness and death in humans, according to a new study published in the journal mBio.

Using a combination of genome sequencing and satellite and environmental data, a team of researchers from the University of Maryland, the University of Florida and microbiome company EzBiome detected several pathogenic Vibrio species in water and oyster samples from Florida's Lee County, a coastal region that was devastated by Hurricane Ian. The samples, which were collected in October 2022, revealed the presence of two particularly concerning species: Vibrio parahaemolyticus and Vibrio vulnificus.

"We were very surprised to be able to detect -- without any difficulty -- the presence of these pathogens," said the study's senior author Rita Colwell, a Distinguished University Professor in the University of Maryland Institute for Advanced Computer Studies (UMIACS) who has studied Vibrio for the last 50 years.

The study's findings correspond with a reported increase in V. vulnificus cases in the state of Florida in October 2022. According to the Florida Department of Health, Lee County, which had the highest caseload in the state, reported 38 infections and 11 deaths linked to vibriosis.

Vibrio bacteria naturally occur in the ocean, where they live symbiotically with crustaceans, zooplankton and bivalves. When the bacteria come in contact with humans, some species can cause an infection known as vibriosis, but the side effects depend on the type of Vibrio and severity of the infection. V. parahaemolyticus can cause gastroenteritis and wound infections, while the V. vulnificus species can cause necrotizing fasciitis -- a flesh-eating infection -- and kills 1 in 5 infected people.

People can contract vibriosis by eating raw or undercooked seafood or by getting seawater in an open wound. Because Vibrio thrive in warm saltwater, hurricanes and floods can increase the chances of a person becoming exposed.

Several conditions during and after Hurricane Ian favored the growth of Vibrio bacteria, including the amount of rainfall, changes in sea surface temperature and concentrations of chlorophyll in the ocean, which can indicate densities of phytoplankton -- and subsequently zooplankton -- in an area. In places with plankton blooms, the researchers found an abundance of Vibrio bacteria.

With warming oceans expected to fuel wetter and more powerful storms like Ian, coastal communities could see more Vibrioinfections in the future.

"These Vibrios generally grow well between 15 and 40 degrees Celsius [59-104 degrees Fahrenheit], so as the temperature warms, their generation time shortens and they divide faster and faster," Colwell said. "The warming of seawater -- which mixes with freshwater, creating optimal salinities -- really enhances the growth of Vibrios, so it's a very serious concern."

While the environmental conditions in Florida following Hurricane Ian were ripe for vibriosis, these cases are not limited to southern climes. In August 2023, three people in New York and Connecticut died from V. vulnificus infections.

Colwell and her co-authors -- which included Kyle Brumfield (Ph.D. '23, marine estuarine environmental sciences) and UMD Cell Biology and Molecular GeneticsResearch Professor Anwar Huq -- predicted this recent spike in vibriosis cases based on trending environmental conditions in the Northeast United States. As ocean temperatures continue to rise, Colwell said the rapidly warming Chesapeake Bay could also be affected.

"The waters are much warmer in Florida right now than they are in the Chesapeake Bay, but on a lot of the East Coast, the waters are warming," Colwell said. "This is a threatening indication that we may be seeing more Vibrio vulnificus infections.

Colwell and her co-authors noted that while they analyzed only a limited number of samples, their findings illustrate the potential of genetic analysis, environmental data and remote sensing to improve public health by proactively detecting and characterizing Vibrio pathogens.

They also called for further investigation to quantify the prevalence of Vibrio bacteria in different locations, seasons and environmental conditions. Colwell said this research is not only vital to public health but also an important step in understanding our changing climate.

"On the positive side, knowing that these infections are associated with the increased variability of a changing climate, perhaps now is the time to develop mechanisms to understand and mitigate it," Colwell said. "Climate change and flooding are clearly linked to infectious disease, and we need to take it seriously."

View post:
New study confirms presence of flesh-eating and illness-causing ... - Science Daily

New Institute for Immunologic Intervention (3i) at the Hackensack … – Hackensack Meridian Health

The new Institute aims to harness and boost immunity to tackle health puzzles - and is already supported by a generous gift from a donor

The Hackensack Meridian Center for Discovery and Innovation (CDI) has formed a new institute aiming to fight infections, cancer, and inflammatory diseases by finding a better way to restore and bolster the human immune system in its responses to disease.

The Institute for Immunologic Intervention (or 3i) is searching for ways to unleash new advances in immunology to beat disease and save lives. The expert scientists in this new institute include basic researchers, physician-scientists, and leading clinicians who are working seamlessly to tackle major health problems of our time.

The Institute is dedicated to advancing the understanding of fundamental mechanisms of infectious immunity, tumor immunity, alloimmunity, and autoimmunity within clinical contexts. By fostering collaborations with the CDI, the John Theurer Cancer Center at Hackensack University Medical Center and its consortium partner Georgetown Universitys Lombardi Comprehensive Cancer Center, and beyond, the 3i strives to apply this knowledge towards innovative strategies that enhance the effectiveness of cancer immunotherapy, interventions for autoimmune and alloimmune conditions, and the prevention of infections.

We have recruited world-class talent to give this Institute critical mass, said David Perlin, Ph.D., chief scientific officer and executive vice president of the CDI, and professor of medical sciences at the Hackensack Meridian School of Medicine. These scientists are tackling disease at the basic level of discovery - but with an eye toward finding real-world solutions in the near future. This is what the CDI is all about. Perlin is also a professor at Georgetown University.

We are excited about the possibilities - and also about the collaborations already happening among this group of scientists, said Binfeng Lu, Ph.D., the director of the 3i.

The scientists whose work is critical to the 3i, and their fields of expertise, include: Lu: cancer immunology and immunotherapy, and inflammatory biology; Yi Zhang, M.D., Ph.D.: (CAR) T cell biology, tumor immunity and alloimmunity; Hai-Hui Howard Xue, M.D., Ph.D.: T cell biology, tumor immunity; Johannes Zakrzewski, M.D.: cancer immunotherapy and immunosurveillance; Rachel Rosenstein, M.D., Ph.D.: inflammatory and fibrotic diseases; Sivia Lapidus, M.D., M.D.: pediatric rheumatic conditions and autoinflammatory disorders; Jigar V. Desai, Ph.D.: innate immunity, fungal infections; Benjamin Tycko, M.D., Ph.D.: genetics and epigenetics in human development and disease; Rena Feinman, Ph.D.: influence of the gut microbiome on antitumor immunosurveillance in patients with multiple myeloma (MM); Kevin Tong, Ph.D.: modeling the genetic progression of colorectal cancer for targeted therapies and personalized medicine; and Alvin Makohon-Moore, Ph.D.: evolutionary dynamics of cancer.

Virtually all of these 3i scientists also have faculty appointments at the Hackensack Meridian School of Medicine.

The research cores supporting the 3i include flow cytometry, microscopy, tissue biorepository bank, bioinformatics and statistical analysis, gene-editing, computational chemistry, and clinical immunology assays, among other expertise.

The expertise brought together in this one Institute at the CDI is a thrilling development, said Ihor Sawczuk, M.D., FACS, president of Academics, Research and Innovation for Hackensack MeridianHealth, the founding chair of the Hackensack MeridianHealthResearch Institute (HMHRI) of which CDI is part, and also associate dean of clinical integration and professor and chair emeritus of urology at the Hackensack Meridian School of Medicine. Working across an ecosystem like this is what will drive our science forward.

The 3i laboratories are all supported by federal grants. Most recently, in support of this mission, the 3i received a philanthropic grant in the amount of $500,000 to support the Institutes work in immunology and multiple myeloma research from the DAloia Family Foundation, led by G. Peter DAloia, an accomplished business executive who previously worked at several large national corporations, and his wife Marguerite. Mr. D'Aloia previously made a major gift to Hackensack Meridian Ocean University Medical Center.

I believe that the CDI has a great approach to finding cures for some of todays most difficult diseases, in particular its work on using the bodys immune system to fight cancer and its focus on treatment and cures for multiple myeloma, said Peter DAloia. It is my hope that this gift provides meaningful help in allowing the CDI to continue the good work being done within the organization.

To make a gift in support of the Institute for Immunologic Intervention (3i) at CDI, please visitGiveHMH.org/CDIor call William Evans, executive director at the CDI, atwilliam.evans@hmhn.orgor 201-880-3100.

Original post:
New Institute for Immunologic Intervention (3i) at the Hackensack ... - Hackensack Meridian Health

Post-doctoral Fellow in Cancer Biology in the Department of … – Times Higher Education

Work type:Full-time Department:Department of Pathology, School of Clinical Medicine (21200) Categories:Senior Research Staff & Post-doctoral Fellow

Applications are invited for appointment asPost-doctoral Fellow in Cancer Biology in the Department of Pathology(Ref.: 523404), to commence as soon as possible for three years, with the possibility of renewal subject to satisfactory performance.

Applicants should have a Ph.D. degree, preferably in cancer biology, molecular biology, cellular biology, immunology, or chemistry-related fields. Research experience involving animal work, cell culture, mass spectrometry, and/or molecular biology would be an advantage. Applicants should be attentive to details, self-motivated, organized, able to multi-task, and able to work independently as well as in a team. The appointee will work with Dr. Carmen Wong on projects related to cancer immunology, cancer metabolism, tumor microenvironment, and/or hypoxia. Enquiries about the post should be sent to Dr. Carmen Wong atcarmencl@pathology.hku.hk.

A highly competitive salary commensurate with qualifications and experience will be offered, in addition to annual leave and medical benefits.

The University only accepts online application for the above post. Applicants should apply online and upload an up-to-date C.V. Review of applications will start on October 20, 2023 and continue untilDecember 31, 2023, or until the post is filled, whichever is earlier.

View post:
Post-doctoral Fellow in Cancer Biology in the Department of ... - Times Higher Education

B cell response after influenza vaccine in young and older adults – EurekAlert

image:

Figure 1.Experimental workflow and subject demographics.

Credit: 2023 Wang et al.

[...] our findings suggest that the age-related decrease in response following influenza vaccination could reflect functional alterations in activated B cells [...]

BUFFALO, NY- October 10, 2023 A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 18, entitled, High-throughput single-cell profiling of B cell responses following inactivated influenza vaccination in young and older adults.

Seasonal influenza contributes to a substantial disease burden, resulting in approximately 10 million hospital visits and 50 thousand deaths in a typical year in the United States. 70 - 85% of the mortality occurs in people over the age of 65. Influenza vaccination is the best protection against the virus, but it is less effective for the elderly, which may be in part due to differences in the quantity or type of B cells induced by vaccination. In their new study, researchers Meng Wang, Ruoyi Jiang, Subhasis Mohanty, Hailong Meng, Albert C. Shaw, and Steven H. Kleinstein from Yale University / Yale School of Medicine investigated this possibility.

[...] we sorted pre- and post-vaccination peripheral blood B cells from three young and three older adults with strong antibody responses to the inactivated influenza vaccine and employed single-cell technology to simultaneously profile the gene expression and the B cell receptor (BCR) of the B cells.

Prior to vaccination, the researchers observed a higher somatic hypermutation frequency and a higher abundance of activated B cells in older adults than in young adults. Following vaccination, young adults mounted a more clonal response than older adults. The expanded clones included a mix of plasmablasts, activated B cells, and resting memory B cells in both age groups, with a decreased proportion of plasmablasts in older adults. Differential abundance analysis identified additional vaccine-responsive cells that were not part of expanded clones, especially in older adults.

To summarize, we showed a quantitative difference in B cell response following vaccination between age groups, with expansion dominated by plasmablasts in the young, and activated B cells in older adults. [...] Overall, this study provides insights into the B cell vaccine response differences between young and older adults and may be beneficial to design more effective vaccines in the older age groups.

Read the full paper: DOI: https://doi.org/10.18632/aging.204778

Corresponding Author: Albert C. Shaw, Steven H. Kleinstein

Corresponding Email: albert.shaw@yale.edu, steven.kleinstein@yale.edu

Keywords: B cell receptor, repertoire, clonal expansion, aging, single-cell RNA-seq

Sign up for free Altmetric alerts about this article: https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.https://doi.org/10.18632/aging.204778

About Aging:

Launched in 2009, Aging publishes papers of general interest and biological significance in all fields of aging research and age-related diseases, including cancerand now, with a special focus on COVID-19 vulnerability as an age-dependent syndrome. Topics in Aging go beyond traditional gerontology, including, but not limited to, cellular and molecular biology, human age-related diseases, pathology in model organisms, signal transduction pathways (e.g., p53, sirtuins, and PI-3K/AKT/mTOR, among others), and approaches to modulating these signaling pathways.

Please visit our website at http://www.Aging-US.com and connect with us:

Click here to subscribe to Aging publication updates.

For media inquiries, please contact media@impactjournals.com.

Aging (Aging-US) Journal Office

6666 E. Quaker Str., Suite 1B

Orchard Park, NY 14127

Phone: 1-800-922-0957, option 1

###

Observational study

People

High-throughput single-cell profiling of B cell responses following inactivated influenza vaccination in young and older adults

26-Jun-2023

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

Excerpt from:
B cell response after influenza vaccine in young and older adults - EurekAlert

Scientists uncover key enzymes involved in bacterial pathogenicity – News-Medical.Net

Gram-negative bacteria cause a variety of infectious diseases in plants and animals alike. Outbreaks of Salmonella and E. coli infections often make headlines due to their severity, and people have to resort to allopathic as well as natural remedies, increasing the burden on the healthcare system. While antibiotics offer an effective solution against bacterial infections, the increasing incidence of antibiotic-resistant bacteria have prompted researchers to identify other possible treatments against these infections. With technological advances and modern medicine, researchers are looking into the possibility of disrupting the pathogenicity of the bacteria at a molecular level by interfering with molecular processes at the gene as well as protein level.

Gram-negative bacteria, notorious for their infection capability, produce osmo-regulated periplasmic glucans (OPGs)-;long-chain carbohydrates made of multiple glucose units-;in the extracellular and/or periplasmic space. Initially, it was believed that OPGs were by-products produced under low solute concentrations, but recent reports confirm that they are crucial for pathogenicity, symbiosis, cell adhesion, and signaling.

However, the enzymes involved in the synthesis, regulation, and degradation of OPGs are not fully known. Genetic analysis revealed that the removal of opgH and/or opgG genes, partially responsible for OPG synthesis, causes bacteria to lose their infection capability, suggesting strong potential links of these genes with bacterial pathogenicity.

Although the structure of OpgG from E. coli (EcOpgG) has been elucidated, the mechanism of action of OpgG and OpgD from E. coli (EcOpgG and EcOpgD, respectively) remains unclear. Understanding the enzymes involved in OPG synthesis and the mechanisms underlying their function could provide us vital insights into the pathogenicity of Gram-negative bacteria, allowing us to develop more effective ways to deal with bacterial infections.

To bridge this gap in knowledge, Mr. Sei Motouchi from Tokyo University of Science, Dr. Kaito Kobayashi from the National Institute of Advanced Industrial Science and Technology (AIST), Associate, Associate Professor Hiroyuki Nakai from Niigata University and Professor Masahiro Nakajima from the Tokyo University of Science conducted structural and functional analyses of EcOpgD and EcOpgG. The study was published in Communications Biology on September 21, 2023.

Sharing the motivation behind this study, Professor Nakajima tells us, "Glycans are important biological macromolecules that play a variety of roles in living organisms, including pathogenicity and symbiosis. Their structure is very diverse and complex, and thus there are many types of enzymes that may synthesize and degrade them. However, we humans know only a small fraction of them".

The researchers investigated the functions of OPG-related genes in the model organism E. coli. Functional analyses revealed that E. coli OpgD (EcOpgD) was an endo--1,2-glucanase, which specifically broke down -1,2-glucans. It also had similar kinetic properties as those of general glycoside hydrolases (GH), further confirming its identity as a -1,2-glucanase.

Structural analysis using crystallography revealed a high degree of similarity between the structures of EcOpgG and EcOpgD. However, the two enzymes had remarkably different activity. Upon further investigation, the researchers found that a few amino acids forming the reaction pathway, termed 'Loop A', were critical for enzyme activity and regulated the rate of reaction. EcOpgG and EcOpgD differed in their catalytic functions, possibly due to the difference in the amino acids in the Loop A region. The LoopA region diversifies among this group of enzymes, which may lead to functional diversity. Nevertheless, the basis of the catalytic center is shared in this group of enzymes. This common point will help scientists develop therapies that could potentially disrupt OPG synthesis and hinder the infection capability of bacteria.

Further, while the two enzymes belonged to the same family of GHs, their structure did not match with any of the existing GH enzymes. Thus, the authors confirmed that they belonged to a novel GH family, namely GH186. This information opens avenues for research into therapies that can target GH186 proteins to stop the progression of bacterial infections.

Professor Masahiro concludes by explaining the long-term applications of the study, "Although it was known that some Gram-negative plant pathogens synthesize OPGs for pathogenicity, most of the key enzymes for their synthesis had not been identified, preventing the development of agrochemicals targeting OPGs. We have identified a family of enzymes (GH186) involved in the direct synthesis of OPGs and elucidated their detailed functions, which has presented us with new targets (GH186) to inhibit pathogens and provides a solid foundation for 'structure-based pesticide discovery'".

The findings of this study lay down a strong foundation for further investigation of OPGs and related genes and may usher in a new era of disease management.

Source:

Journal reference:

Motouchi, S., et al. (2023). Identification of enzymatic functions of osmo-regulated periplasmic glucan biosynthesis proteins from Escherichia coli reveals a novel glycoside hydrolase family. Communications Biology. doi.org/10.1038/s42003-023-05336-6.

Read the original post:
Scientists uncover key enzymes involved in bacterial pathogenicity - News-Medical.Net

Soft-landing methods aim to simplify structural biology – Nature.com

A mass spectrometer modified by Stephan Rauschenbachs team reduces damage to proteins so they can be used in cryo-electron microscopy.Credit: Tim Esser

In his lecture after winning a share of the 2002 Nobel Prize in Chemistry, John Fenn described his work as creating wings for molecular elephants.

Fenn pioneered the use of a method called electrospray ionization (ESI) to make intact proteins among natures beefiest biomolecules literally fly, transferring them from complex mixtures into gases and then into mass spectrometers for extensive analysis. Alongside the research of co-recipient Koichi Tanaka, Fenns work1 made it possible for scientists to dive deep into the chemical composition and therefore the sequences, chemical modifications and molecular partners of whole proteins, using mass spectrometry.

Such data can be invaluable for basic research and biopharmaceutical development but not protein-structure determination. A growing number of researchers, however, are enthusiastic about the idea of hooking up the technique to a technology that can fill that gap. Using ESI mass spectrometry as an air traffic control system to facilitate the take-off, flight and gentle touchdown of intact proteins, in preparation for state-of-the-art methods such as cryo-electron microscopy (cryo-EM), could greatly expand the range of protein structures that can be solved with these powerful but finicky methods. Yet whether its possible to land Fenns winged molecular elephants safely has remained unclear.

Catching proteins at play: the method revealing the cells inner mysteries

Much excitement, therefore, accompanied an August preprint2 from researchers led by physical chemist Stephan Rauschenbach at the University of Oxford, UK. It presented a near-atomic-resolution cryo-EM structure for the enzyme -galactosidase after preparation with a mass-spectrometry-based approach known as electrospray ion-beam deposition (ES-IBD). The sugar-metabolizing enzyme is one of the best-characterized proteins, making it an ideal test bed for whether soft landing mass-spectrometry methods such as ES-IBD can deliver the goods. By tuning the acceleration of a protein as it travels through the mass spectrometer, soft-landing methods aim to limit the force with which the protein arrives at its final destination, thereby minimizing the resulting damage. Everybody can get a good structure of -galactosidase but not after taking it through a mass spectrometer, landing it and visualizing it, says chemist Carol Robinson, who collaborated with Rauschenbach and is also at the University of Oxford.

The researchers results revealed a protein that was somewhat crumpled and dehydrated, but that still closely resembled conventional cryo-EM structures. A July preprint3 from a team led by biomolecular chemist Joshua Coon and structural biologist Timothy Grant, both at the University of WisconsinMadison, also reported natural-looking albeit moderate-resolution cryo-EM structures for multiple proteins.

Enthusiasts see the possibility of a facile sample-preparation method that allows researchers to generate near-atomic-resolution protein structures with unprecedented precision and efficiency. It has the potential to be the default way people prepare samples for cryo-EM, says Coon. Other modes of structural analysis could also benefit, including single-molecule methods that actively monitor the dynamics of flexible proteins. But few groups have made headway with soft-landing mass spectrometry, and the promising results that have been obtained are insufficient to allay concerns that proteins reaching the microscope do not fully retain their natural structure. Its a very exciting subfield, concludes Alexis Rohou, a structural biologist at the biotechnology firm Genentech in South San Francisco, California. But there are many, many things yet to be overcome.

The marriage of ESI mass spectrometry and cryo-EM is the product of difficulties in two fields.

Native protein analysis with ESI mass spectrometry entails ejecting proteins from a liquid environment to form airborne gas phase particles in a vacuum. This allows researchers to study the biochemical characteristics of intact proteins, as opposed to smaller chunks called peptides, but whether protein structures are fundamentally disrupted by this transition has been the subject of a long-standing debate.

People were saying to me, You cant really believe that this looks anything like it does in crystallography or in electron microscopy surely being in the gas phase has ruined the structure to some extent, says Robinson, a specialist in native mass spectrometry. She was convinced otherwise, however, and early experiments supported her view. In 2003, for instance, chemist R. Graham Cooks and his colleagues at Purdue University in West Lafayette, Indiana, generated arrays of soft-landed enzymes that remained functional despite their arduous journey4. Around a decade later, Robinsons team used transmission electron microscopy (TEM) to show that the structural features of well-studied protein complexes were generally preserved after soft-landing mass spectometry5.

A reconstruction of the -galactosidase enzyme after soft-landing mass spectrometry.Credit: Colin Hemme

TEM is not suitable for defining the structure of protein molecules at high resolution, but cryo-EM is. In cryo-EM, large numbers of protein molecules are trapped in a thin layer of glass-like ice on a sample grid under conditions that preserve their fine structural features. These frozen protein molecules are imaged at different angles, and then the images are computationally reconstructed into a 3D shape. A good cryo-EM experiment can reveal protein structures with atomic resolution, and the method is now a mainstay of structural biology, with more than 15,000 structures deposited in the worlds repository for protein structures: the Protein Data Bank.

But cryo-EM users have a struggle of their own: sample preparation. At least half the time, you just cant get it to work, says Grant. And for certain proteins, its all the time. At the freezing stage, protein specimens exist in a thin film of solution that leaves them exposed to air, which can induce protein unfolding and degradation, Grant says. This airwater interface can also cause proteins to preferentially adopt specific orientations. Without a diversity of orientations, it becomes impossible to generate a high-quality cryo-EM reconstruction. Soft-landing mass spectrometry could help to eliminate that bias.

Furthermore, by including soft-landing mass spectrometry in the earliest stages of sample preparation, cryo-EM users could spare themselves the trouble of purifying their proteins and instead pluck them directly from samples on the basis of the proteins size and biochemical characteristics. Maybe you could amplify a single population and only deposit that on a grid, or only deposit that in one region of the grid so that another region has proteins in a different state, says biochemist James Evans, who is part of the leadership team for the Pacific Northwest Cryo-EM Center in Portland, Oregon.

The successful integration of soft-landing mass spectrometry with cryo-EM could therefore resolve two pressing issues the gas-phase controversy and protein-sample preparation at a stroke. But getting to that point has proved harder than expected.

With any aerial routine, one of the biggest challenges is to make a perfect landing and so it was with soft-landing mass spectrometry. We started more than 20 years ago, recalls Klaus Kern, a chemist at the Max Planck Institute for Solid State Research in Stuttgart, Germany, who supervised Rauschenbachs initial work on ES-IBD as a postdoc. It took 1012 years before it really started working.

The instrumentation itself can be built around a commercial mass spectrometer both Coon and Rauschenbach have used Orbitrap instruments, from US biotechnology company Thermo Fisher Scientific, as a foundation. But considerable tuning and modification are required to protect the integrity of the protein molecule during transit and to manage its speed and eventual impact with the sample grid. Careful optimization of both the sample-preparation conditions and the surface of the landing pad are also required.

Coon recalls reaching out to Grant early in their collaboration to show off some of the data his team had produced. We were all proud of these images, and we said, Tim, what do you think? And hes like, Your proteins are shit, they look kind of like you threw a tomato at a wall, Coon says. His team spent about 18 months testing different instrumentation and sample and surface conditions before finding a formula that worked: coating sample grids with an ultra-thin layer of glycerol to capture the landed proteins. Using TEM, the researchers confirmed successful deposition of seemingly intact GroEL a cylindrical chaperone protein that enables the folding of other proteins with modest resolution. But the workflow was incompatible with cryo-EM, because glycerol produces too much noise in the images, and so they went back to the drawing board to make their process more cryo-friendly. The results were published in April 20226.

Months later, Rauschenbach and his colleagues described an approach that came closer to a standard cryo-EM workflow7. They deposited gas-phase proteins onto a room-temperature, unmodified grid, which they then plunged into liquid nitrogen to freeze the proteins in place without forming an ice layer. Rauschenbach was pleased to note that the structure of -galactosidase looked more or less correct, and his team saw evidence of features such as -helices and -sheets. Even at room temperature, something was retained, he says. But the resolution was not good enough to fit models.

The entire protein universe: AI predicts shape of nearly every known protein

Rauschenbach and Coon independently realized that freezing the proteins as soon as they leave the vacuum environment of the mass spectrometer could solve that problem. Both teams described important progress towards the use of soft-landing mass spectrometry for cryo-EM sample preparation in the July and August preprints2,3. Coon and Grants group achieved3 this by landing the proteins on a grid that it had pre-chilled to 190C. The researchers then restored the grid to atmospheric pressure before plunging it into liquid nitrogen. By contrast, Rauschenbachs team coated its mass-spectrometry-deposited proteins with a thin ice layer by introducing low levels of water vapour into the sample chamber, which quickly froze on the surface of the pre-chilled grid2. Rauschenbach says that his teams ice-free samples tend to form problematic artefacts, but when you embed them in ice, you get the structure.

The results have led to cautious optimism. Both groups saw considerable improvements in the resolution that they could obtain for -galactosidase, and Coons group also obtained a higher-quality 3D structure for GroEL compared with the earlier work using glycerol. In fact, Rauschenbach and his colleagues achieved a resolution of 2.6 ngstrms about the length of a hydrogen bond, and slightly poorer than results obtained with conventional cryo-EM samples.

But his teams reconstruction of -galactosidase was somewhat compacted relative to the proteins known structure. The researchers surmised that the enzymes journey through a harsh vacuum environment stripped away the water molecules that surround proteins in nature, causing it to dehydrate and shrivel. The important point is [that] this is not the solution structure it is a gas-phase protein landing on a cold surface, Rauschenbach explains. In their preprint, the researchers showed that they could largely restore the correct structure using an algorithm that simulates protein hydration.

The significance of this dehydration for sample preparation is unclear. On the one hand, these results largely vindicate researchers such as Robinson, who posited that gas-phase proteins generally retain their structure. On the other hand, structural biologists seeking a route for preparing intact native proteins are still awaiting more evidence. How much dehydration damages the protein is, I think, a somewhat open question, says Grant. He and his team are continuing to test other proteins in their workflow Coon says that they prepare four to five new grids daily in the hope that they can improve understanding of what happens during the soft-landing mass-spectrometry process.

But Tanmay Bharat, a structural biologist at the MRC Laboratory of Molecular Biology in Cambridge, UK, who collaborated with Rauschenbach, is optimistic about the method already. Its a very good starting point for improving the process even more, he says, although he notes that further work will be required to turn it into a robust and generalizable protocol for protein cryo-EM. Both teams are looking into opportunities to use mass spectrometry with proteins that retain at least a partial water coating and can therefore be frozen in a more natural state.

Biomolecular chemist Joshua Coon (right) and his team spent 18 months optimizing equipment and conditions for soft-landing mass spectrometry.Credit: David Nevala

Other groups have begun testing the waters of soft-landing mass-spectrometry. For example, Rohou and his colleagues at Genentech are working with an ion mobility deposition method developed by life-science company IonDx in Monterey, California, which allows the sorting of proteins that remain fully hydrated and therefore could retain more native structures. The team still struggles to land intact proteins on its grids, says Rohou, but they have frozen water and protein in them, and we can recognize proteins in each individual droplet.

Similarly, Evans and his collaborator Ljiljana Paa-Toli, a mass-spectroscopy specialist at Pacific Northwest National Laboratory in Richland, Washington, who have also stumbled with soft-landing mass spectrometry, are exploring an alternative approach. Known as Structures for Lossless Ion Manipulation (SLIM), it operates under softer vacuum conditions and could therefore reduce the loss of water. Youre still under some vacuum, but you may be able to create and keep a shell of hydration or a salt shell even around the protein, says Evans.

For cryo-EM enthusiasts, the current state of limbo is both exciting and frustrating. Its almost like its binary you can either do it all or do nothing, says Grant. And right now, nobodys done it all. And the consequences of turning this into a robust, lab-ready technique could be huge.

The must-have multimillion-dollar microscopy machine

Integrated into the cryo-EM workflow, soft-landing mass spectrometry could allow more-elaborate experiments. You could lyse a cell and basically pick out complexes of certain molecules with certain other molecules, says Bharat, or more precisely characterize the interactions between drug candidates and target proteins. The integration could also make small proteins more amenable to cryo-EM analysis. Such proteins are typically invisible in the relatively thick layers of ice formed by current plunge-freezing methods, Rohou explains. A mass-spectrometry-based method that either eliminates the need for ice or reduces it to a thin shell around the protein could make these proteins tractable for high-resolution analysis.

But soft-landing mass spectrometry is already creating exciting possibilities for protein analysis at the single-molecule level. Kern, Rauschenbach and their colleagues initially began exploring soft-landing mass spectrometry as a preparative tool for characterizing proteins and other biomolecules with an approach called scanning tunnelling microscopy (STM). This involves a tiny, ultrasharp probe being manoeuvred over an immobilized sample while a voltage is applied; bumps and divots in the sample surface produce changes in the resulting current, which can then be mapped to determine the underlying sample structure. In 2020, Kern and his colleagues demonstrated for the first time that STM could reveal the structure of complex carbohydrates that had been deposited by soft-landing mass spectrometry8. His team is now extending the approach to analyse glycoproteins in unprecedented detail. We can directly see what glycan is attached to what amino acid in a polypeptide, says Kern.

Kerns team is also integrating soft-landing mass spectrometry with a relatively obscure STM variant known as low-energy electron holography (LEEH), to recover information about flexible proteins that can adopt multiple conformations. In LEEH, the ultrasharp probe serves as an electron source that bombards a target molecule on an ultraclean layer of graphene, producing an interference pattern that can be reconstructed to determine the targets 3D structure. Theoretically, the process can achieve near-atomic resolution, Kern notes. But his team has already clearly distinguished different structural configurations of a protein of interest a scenario that would create only blurry images in cryo-EM9.

These developments are just the beginning for soft-landing mass spectrometry, and for Rauschenbach, thats the most exciting aspect: the untapped versatility. You can do all types of chemistry, deposition and analysis methods, he says. We can use it for so many things.

See the rest here:

Soft-landing methods aim to simplify structural biology - Nature.com

Missing ‘Law of Nature’ Found That Describes The Way All Things Evolve – ScienceAlert

Complex, evolving systems abound in our Universe, even beyond the realms of biology. From the growth of stars to prebiotic chemistry, diverse mixes of materials can often be shaped into far more complex forms.

Yet unlike other so many other physical phenomena, their changing nature is yet to be represented by a discrete law.

That's according to a US team of astrobiologists, philosophers, a mineralogist, a theoretical physicist, and a data scientist who describe the "missing law" of nature in an intriguing new peer-reviewed paper.

"Given the ubiquity of evolving systems in the natural world, it seems odd that one or more laws describing their behaviors have not been more quickly forthcoming," the authors write.

The team's own "law of increasing functional information" says evolution in all its forms inevitably leads to more patterning, diversity, and complexity in natural complex systems.

Evolution is certainly not unique to Earth's biosphere; it takes place in other extremely complex systems, such as our Solar System, stars, atoms, and minerals.

"The Universe generates novel combinations of atoms, molecules, cells, etc," says first author of the study, astrobiologist Michael Wong from Carnegie Institution for Science in Washington, DC.

"Those combinations that are stable and can go on to engender even more novelty will continue to evolve. This is what makes life the most striking example of evolution, but evolution is everywhere."

The paper describes how just hydrogen and helium the two most abundant elements at the time of the Big Bang coalesced to form the first stars. By the time a star reaches the end of its life it can generate more than 100 elements with around 2000 varieties of isotope.

On Earth, an enormous diversity of mineral 'species' were created from simple beginnings as the planet formed across 4.55 to 2.5 billion years ago. There are now more than 5,900 known mineral species on Earth, which became increasingly chemically complex as emerging forms of life released oxygen into the atmosphere.

Iron's reaction with oxygen-based minerals ushered in a new era in ancient life and laid the groundwork for our own evolution in tandem with other minerals.

The complexity of Earth's surface mineralogy grew further as life evolved from single-celled to multicellular organisms and ecosystems formed. The wide range of minerals that were formed changed the course of evolution and its options.

Biological and mineral systems continually interact to influence each other's diversity, and life as we know it is the result of this interaction.

"These evolving systems appear to be conceptually equivalent in that they display three notable attributes," the authors write.

"1) They form from numerous components that have the potential to adopt combinatorially vast numbers of different configurations; 2) processes exist that generate numerous different configurations; and 3) configurations are preferentially selected based on function."

So, is there something in the way information can be transferred that accounts for the shared characteristics of seemingly diverse evolving systems? Could there be a universal basis for selection? The team thinks both answers are yes.

"An important component of this proposed natural law is the idea of 'selection for function,'" says Wong.

According to Darwin, an organism's primary function in the context of biology is to ensure its own survival long enough to reproduce successfully. The team says this new proposal broadens our understanding by pointing out the existence of three distinct types of function in the natural world.

The most fundamental function we could call 'static persistence' maintenance of stable atomic or molecular arrangements.

'Dynamic persistence' describes how systems that are dynamic and have access to constant sources of energy are also more likely to endure.

And lastly, 'novelty generation' refers to the propensity of evolving systems to generate novel configurations, which can result in surprising novel behaviors or characteristics.

Wong and team point out that physical laws of motion, gravity, electromagnetism, and thermodynamics govern the functions of macroscopic natural systems across space and time. So it makes sense that we should have a law of nature for evolution.

"An asymmetric trajectory based upon functionality may seem antithetical to scientific analysis," the team concludes.

"Nevertheless, we conjecture that selection based on static persistence, dynamic persistence, and novelty generation is a universal process that results in systems with increased functional information."

The study has been published in Proceedings of the National Academy of Sciences.

Read the original here:

Missing 'Law of Nature' Found That Describes The Way All Things Evolve - ScienceAlert

Nightwing Secretly Has 1 Superpower (Because Alfred Messed with His Biology) – Screen Rant

Nightwing, much like the majority of the Bat-Family, is held in high regard for his status as a non-meta hero, making him one of the most formidable and esteemed heroes in the DC universe, despite lacking superhuman abilities. However, it has come to light that Nightwing possesses a unique superpower, which distinguishes him from all others, and it's all thanks to his loyal butler and grandfather figure, Alfred Pennyworth.

Battle for the Cowl #3 written by Tony Daniel made it strikingly clear that Nightwing possesses a unique resistence to the fear toxin used by infamous supervillain Scarecrow.

As it turns out, Nightwing's exceptional immunity to fear gas was granted to him through Alfred's meticulous inoculation of the Boy Wonder against every known variant of this hallucinogenic drug.

Related: Scarecrow Works Much Better as Nightwing's Villain Than Batman's

Within the daunting landscape of Gotham City, Nightwing, and the Bat-Family confront an endless array of nightly threats, many of which stem from Batman's notorious Rogues Gallery. Among these iconic adversaries, few can induce as much spine-chilling dread as Scarecrow. Armed with his infamous 'fear toxin,' a potent hallucinogenic concoction of his own creation, Scarecrow immerses his victims in their darkest nightmares, subjecting them to unparalleled terror. It's a nightmarish weapon that strikes fear into the hearts of even the bravest souls. Nevertheless, Nightwing's unique superpower enables him to confront the fear toxin in a manner distinct from any other hero or villain.

This remarkable resistance to fear-inducing substances becomes strikingly evident in a memorable scene from Battle for the Cowl #3, when Nightwing finds himself unwittingly dosed with fear gas by Red Hood, the once-second Robin. However, the potent fear agent proves utterly ineffective against him, causing, at most, a hint of disorientation. This remarkable immunity is effectively Nightwing's overlooked 'superpower,' the envy of every Gotham citizen. Dick Grayson's immunity to fear gas grants him a distinct advantage. While most individuals would find themselves entirely incapacitated when exposed to fear gas, a substance known for its debilitating and, sometimes lethal effects, Dick has repeatedly demonstrated his imperviousness to its influence.

Alfred inoculating Dick against fear gas may have been a boon for the hero in the long run, and the hero community for that matter, but it does call into question the ethics of Alfreds decision, since this was most likely done during Dicks Robin years, where he would have been still just a boy, and couldnt have given proper consent. As apparent in Battle for the Cowl # 3, Nightwing doesnt hold this against Alfred, since he mentions the tampering to his biology in a nonchalant and positive context, but it still is a decision made on Pennyworth's part that may not have been one of his most ethical.

This extraordinary resilience is vividly showcased in Nightwing Vol. 4 #56 by Scott Lobdell, Fabian Nicieza, and Davide Gianfelice, during the 'Ric' storyline. In an encounter with Scarecrow, the villain doses the vigilante with the toxin; Dick Grayson remains utterly unaffected. This unique ability has the potential to be a pivotal factor in future storylines, where the tide of a crisis involving fear gas could be shifted by Dick's exceptional immunity. In such scenarios, Nightwing may emerge as the sole hero capable of saving the day, highlighting the profound significance of his immunity in the face of perilous encounters with this menacing hallucinogenic substance.

Go here to read the rest:

Nightwing Secretly Has 1 Superpower (Because Alfred Messed with His Biology) - Screen Rant